What Researchers have Learned about the Marijuana Compound Cannabigerol or CBG
Cannabigerol (CBG) is the phytocannabinoid precursor molecule, and demonstrates weak partial agonism at CB1 and CB2. In vitro studies show, CBG displays analgesic and anti-erythemic effects. CBG also displays anti-hypertensive activity and has cytotoxic activity against human epithelioid carcinoma and human breast cancer cells. CBG has many other pharmacological properties.